Mymd Pharmaceuticals Stock Price To Sales
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
MyMD Pharmaceuticals fundamentals help investors to digest information that contributes to MyMD Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MyMD Stock. The fundamental analysis module provides a way to measure MyMD Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MyMD Pharmaceuticals stock.
MyMD |
MyMD Pharmaceuticals Company Price To Sales Analysis
MyMD Pharmaceuticals' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, MyMD Pharmaceuticals has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
MyMD Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MyMD Pharmaceuticals' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics of similar companies.MyMD Pharmaceuticals is currently under evaluation in price to sales category among its peers.
MyMD Fundamentals
| Return On Equity | -1.01 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | 2.99 M | |||
| Shares Outstanding | 2.37 M | |||
| Shares Owned By Insiders | 6.61 % | |||
| Shares Owned By Institutions | 6.62 % | |||
| Number Of Shares Shorted | 263.62 K | |||
| Price To Book | 0.46 X | |||
| EBITDA | (17.12 M) | |||
| Net Income | (4 M) | |||
| Cash And Equivalents | 5.62 M | |||
| Cash Per Share | 0.15 X | |||
| Total Debt | 48.87 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.41 X | |||
| Book Value Per Share | 4.54 X | |||
| Cash Flow From Operations | (12.98 M) | |||
| Short Ratio | 2.71 X | |||
| Earnings Per Share | (9.27) X | |||
| Beta | 2.69 | |||
| Market Capitalization | 4.31 M | |||
| Total Asset | 17.86 M | |||
| Retained Earnings | (101.98 M) | |||
| Working Capital | 828.25 K | |||
| Net Asset | 17.86 M |
About MyMD Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MyMD Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |